Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
Abstract Background The Bacillus Calmette-Guérin (BCG) preparations are live-attenuated derivatives of Mycobacterium bovis. These products are used to vaccinate infants at birth, a practice that may result in a disseminated infection in those patients who have an unidentified immunodeficiency. Case...
Main Authors: | Suleiman Al-Hammadi, Ahmed R. Alsuwaidi, Eman T. Alshamsi, Ghassan A. Ghatasheh, Abdul-Kader Souid |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-05-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-017-2499-7 |
Similar Items
-
Genomic characteristics of two most widely used BCG vaccine strains: Danish 1331 and Pasteur 1173P2
by: Mahla Asadian, et al.
Published: (2022-08-01) -
Disseminated Bacillus Calmette-Guérin Infection and Immunodeficiency
by: Ewa Anna Bernatowska, et al.
Published: (2007-05-01) -
Grupo Técnico de Estudos do BCG em Câncer Vacina BCG (Bacillus Calmette-Guérin)
by: Humberto Torloni, et al.
Published: (2023-08-01) -
DISSEMINATED BACILLUS-CALMETTE-GUÉRIN INFECTIONS AND PRIMARY IMMUNODEFICIENCY DISORDERS IN SINGAPORE: A SINGLE CENTER 15-YEAR RETROSPECTIVE REVIEW
by: Rina Yue Ling Ong, et al.
Published: (2020-08-01) -
A case of disseminated M. bovis bacillus Calmette-Guérin (BCG) disease after one month of BCG bladder infusion therapy and analysis of 77 cases of suspected BCG infection in Japan, 2017–2022
by: Masashi Nishimura, et al.
Published: (2023-01-01)